Migratory responses, either towards increasing concentrations of chemo attractants (FBS) in migration assay, or filling the scratched area (wound healing assay), demonstrated that CCR5 inhibition significantly hinders the directional migration of CRC cells (Fig. 2b, c). The gene discussed is CCR5; the disease is colorectal carcinoma.